{ }
001122334455554433221100
001122334455554433221100

Swiss companies commit to science based targets for CO2 reduction

A total of 224 Swiss companies have committed to CO2 reduction targets aligned with the Paris Climate Agreement by joining the Science Based Targets initiative (SBTi). This includes major corporations like ABB, Givaudan, and Nestlé, with over 80 new members since the start of the year. Only three companies have withdrawn from the initiative.

swiss stock exchange declines as investors react to us interest rate concerns

The Swiss stock exchange closed lower, with the SMI down 0.70% at 8206.20 points, following concerns over potential U.S. interest rate hikes. Major banks like UBS and Credit Suisse faced significant losses, while defensive stocks like Nestlé and Novartis attempted to mitigate the downturn. Market experts anticipate a turbulent period ahead after recent volatility in U.S. markets.
17:32 15.11.2024

ubs maintains neutral rating for givaudan with target price of 4520 francs

UBS has maintained a 'Neutral' rating for Givaudan, setting a target price of 4,520 Swiss francs. Analyst Charles Eden also highlighted DMS-Firmenich, Symrise, and Croda as attractive investment options in the flavor and fragrance sector for the upcoming quarter.
14:42 15.11.2024

ubs upgrades givaudan to neutral with target price of 4520 francs

UBS has maintained a "Neutral" rating for Givaudan, setting a price target of 4,520 Swiss francs. Analyst Charles Eden identified DMS-Firmenich, Symrise, and Croda as attractive investment options in the flavor and fragrance sector for the upcoming quarter.
13:54 15.11.2024

ubs maintains neutral rating for givaudan with target price of 4520 francs

UBS has maintained a "Neutral" rating for Givaudan, setting a target price of 4,520 francs. Analyst Charles Eden identified DMS-Firmenich, Symrise, and Croda as attractive investment options in the flavor and fragrance sector during the final quarter reporting season.
13:54 15.11.2024

ubs maintains neutral rating for givaudan with target price of 4520 francs

UBS AG has maintained a "Neutral" rating for Givaudan shares, setting a target price of 4,520 francs, despite concerns over potential sales slowdowns in Q4. Currently priced at CHF 3,836.00, the shares have a 17.83% upside potential and have risen 12.0% since the start of 2024. Key Q4 figures are expected on January 24, 2025.
12:28 14.11.2024

UBS maintains neutral rating for Givaudan with target price of 4520 francs

UBS has maintained a "Neutral" rating for Givaudan with a target price of 4,520 francs, following a recent conference. Analyst Charles Eden noted that there are no indications of a sales slowdown anticipated for the final quarter, alleviating previous concerns.
11:37 14.11.2024

Swiss stock exchange declines as banking and cyclical stocks face pressure

The Swiss stock exchange experienced a downward trend, with the SMI index closing at 8056.71 points, down 0.35%. Banking stocks faced pressure due to uncertainties surrounding Brexit and low interest rates, while defensive heavyweights like Novartis and Nestlé showed slight gains. In the broader market, Sulzer surged 11.47% following its acquisition of Geka, while EFG International struggled, dropping 6.30%.
18:59 09.11.2024

tea extracts market projected to reach 5.88 billion by 2031

The tea extracts market is projected to grow from US$ 3.58 billion in 2023 to US$ 5.88 billion by 2031, driven by increasing consumer demand for natural ingredients and health-focused products. Key applications include food & beverages, dietary supplements, and personal care, with significant growth opportunities in the cosmetic industry, particularly in Asia. Major players include Finlays, Botanic Healthcare, and Firmenich International, focusing on innovative and affordable products to meet market needs.

ubs maintains buy rating for symrise with target price of 139 euros

UBS AG maintains a "Buy" rating for Symrise shares, setting a target price of 139 euros, despite a 2.8% drop to EUR 112.35. Analyst Charles Eden noted that organic sales growth expectations were raised, but the third quarter's performance was partly negative compared to strong competitor results. The share has a potential upside of 23.72% relative to the target price, with a 14.0% gain over 2024, and Q4 earnings and sales figures are anticipated on March 5, 2025.
10:43 24.10.2024

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.